ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,431.60
      -0.04%
      US Tech 100
      19,168.00
      0.52%
      Dow Jones
      38,589.16
      -0.15%
      Brent Oil
      82.275
      0.00%
      Bitcoin
      66,219.99
      0.33%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Pyxis Oncology Inc (PYXS)

      7. Pyxis Oncology Inc (PYXS) News

      PYXS

      Pyxis Oncology (PYXS)

      Pyxis Oncology Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:PYXS
      DateTimeSourceHeadlineSymbolCompany
      06/12/20244:17PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PYXSPyxis Oncology Inc
      06/10/20247:56AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PYXSPyxis Oncology Inc
      06/10/20247:30AMGlobeNewswire Inc.Pyxis Oncology Expands Board of Directors with Appointment of Michael A. MetzgerNASDAQ:PYXSPyxis Oncology Inc
      06/07/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PYXSPyxis Oncology Inc
      05/30/20247:30AMGlobeNewswire Inc.Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare ConferenceNASDAQ:PYXSPyxis Oncology Inc
      05/14/20248:00AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PYXSPyxis Oncology Inc
      05/14/20247:55AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PYXSPyxis Oncology Inc
      05/14/20247:30AMGlobeNewswire Inc.Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024NASDAQ:PYXSPyxis Oncology Inc
      05/09/20247:30AMGlobeNewswire Inc.Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare ConferenceNASDAQ:PYXSPyxis Oncology Inc
      03/28/20244:30PMGlobeNewswire Inc.Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PYXSPyxis Oncology Inc
      03/27/20247:30AMGlobeNewswire Inc.Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty RightsNASDAQ:PYXSPyxis Oncology Inc
      03/21/20247:30AMGlobeNewswire Inc.Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023NASDAQ:PYXSPyxis Oncology Inc
      03/13/20248:00AMGlobeNewswire Inc.Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFANASDAQ:PYXSPyxis Oncology Inc
      03/08/20244:03PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PYXSPyxis Oncology Inc
      03/07/20244:30PMGlobeNewswire Inc.Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024NASDAQ:PYXSPyxis Oncology Inc
      03/05/20244:45PMGlobeNewswire Inc.Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual MeetingNASDAQ:PYXSPyxis Oncology Inc
      02/28/20247:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PYXSPyxis Oncology Inc
      02/27/20248:00AMGlobeNewswire Inc.Pyxis Oncology Announces $50 Million Private PlacementNASDAQ:PYXSPyxis Oncology Inc
      12/29/20234:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PYXSPyxis Oncology Inc
      12/29/20234:30PMGlobeNewswire Inc.Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PYXSPyxis Oncology Inc
      12/06/20234:50PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PYXSPyxis Oncology Inc
      11/30/20234:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PYXSPyxis Oncology Inc
      11/28/20237:22AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PYXSPyxis Oncology Inc
      11/28/20237:00AMGlobeNewswire Inc.Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical OfficerNASDAQ:PYXSPyxis Oncology Inc
      11/17/20234:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PYXSPyxis Oncology Inc
      11/07/20234:46PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PYXSPyxis Oncology Inc
      11/07/20234:44PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PYXSPyxis Oncology Inc
      11/07/20234:30PMGlobeNewswire Inc.Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate UpdateNASDAQ:PYXSPyxis Oncology Inc
      10/27/20234:34PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:PYXSPyxis Oncology Inc
      09/28/20234:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PYXSPyxis Oncology Inc
       Showing the most relevant articles for your search:NASDAQ:PYXS